Foghorn Therapeutics Inc. (FHTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 340.1M |
| Enterprise Value | 300.49M |
| P/E Ratio | -7.14 |
| PEG Ratio | -0.4 |
| Price/Sales Ratio | 11.3 |
| Price/Book Ratio | -6.16 |
| Enterprise/Revenue | 10.62 |
| Enterprise/EBITDA | -6.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.76 |
| Operating Margin | -1.86 |
AD
Management Effectiveness
| Return On Assets | -0.32 |
| Return On Equity | 0.73 |
Income Statement
| Revenue | 30.91M |
| Revenue/Share | 0.52 |
| Gross Profit | 27.58M |
| EBITDA | -70.95M |
| Net Income | -74.28M |
| Diluted EPS | -1.18 |
Balance Sheet
| Total Cash | 167.58M |
| Total Cash/Share | 2.37 |
| Total Debt | 43.1M |
| Total Debt/Equity | -0.53 |
| Current Ratio | 3.36 |
| Book Value Per Share | -1.15 |
Price History
| 52-Week Change | 27.16 |
| 52-Week High | 7.61 |
| 52-Week Low | 3.27 |
| Moving Average 50 Days | 5.27 |
| Moving Average 200 Days | 5.03 |
Statistics
| Average Volume | 290,788 |
| Shares Outstanding | 58.71M |
| % Held by Institutions | 70.56 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
